• $245,153.00
    Market Cap
  • -83.87%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
08/31/2025
08/31/2024
08/31/2023
08/31/2022
Income Statement
Total Operating Revenue
0
-100.00%
130,074
-68.29%
410,165
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
-100.00%
130,074
-68.29%
410,165
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
0
-100.00%
1,223
-92.35%
15,977
-21.08%
Research and Development Expense
0
+100.00%
-194,788
-54.86%
-431,565
-63.53%
-1.2M
-33.21%
Depreciation and Amortization Expense
0
-100.00%
72,320
-55.37%
162,061
-18.37%
198,527
-10.14%
Total Operating Expenses
271,691
-61.91%
713,214
-46.84%
1.3M
-54.59%
3.0M
+13.61%
Operating Profit
-271,691
-53.41%
-583,139
-37.39%
-931,380
-68.47%
-3.0M
+13.61%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Interest Expense
-39,813
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
-39,813
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
-39,813
-272.17%
23,124
-56.06%
52,623
-93.16%
769,280
+229.45%
Income before Taxes
-271,691
-53.41%
-583,139
-37.39%
-931,380
-68.47%
-3.0M
+13.61%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-313,976
-54.84%
-695,198
-81.26%
-3.7M
-0.35%
-3.7M
+16.55%
Net Income from Continuing Operations Applicable to Common
N/A
N/A
-695,198
-81.26%
-3.7M
-0.35%
-3.7M
+16.55%
Basic EPS and Net Income
0.00
+100.00%
-0.02
-95.24%
-0.42
-88.30%
-3.59
+17,850.00%
Diluted EPS and Net Income
0.00
+100.00%
-0.02
-95.24%
-0.42
-88.30%
-3.59
+17,850.00%
Basic Weighted Average Shares
90.6M
+199.69%
30.2M
+242.76%
8.8M
+621.77%
1.2M
-99.12%
Diluted Weighted Average Shares
90.6M
+199.69%
30.2M
+242.76%
8.8M
+621.77%
1.2M
-99.12%
Balance Sheet
Cash and Cash Equivalents
15,111
-42.80%
26,416
-79.63%
129,696
+10.37%
117,515
-91.52%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
15,111
-42.80%
26,416
-79.63%
129,696
+10.37%
117,515
-91.52%
Total Current Assets
18,437
-41.25%
31,383
-86.01%
224,308
+13.12%
198,287
-87.54%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
0
N/A
0
-100.00%
274,731
-37.10%
436,792
-32.06%
Total Long-Term Assets
0
N/A
0
-100.00%
274,731
-37.10%
436,792
-32.06%
Total Assets
18,437
-41.25%
31,383
-93.71%
499,039
-38.48%
811,166
-73.65%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
1.2M
-7.56%
1.3M
-3.61%
1.3M
-23.60%
1.8M
+101.71%
Total Current Liabilities
2.5M
+0.13%
2.5M
-0.20%
2.5M
+2.98%
2.4M
+91.94%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
2.5M
+0.13%
2.5M
-0.20%
2.5M
+2.98%
2.4M
+91.94%
Retained Earnings
-25.3M
+1.26%
-25.0M
+2.87%
-24.3M
+18.06%
-20.5M
+22.13%
Total Stockholders Equity
-2.5M
+0.66%
-2.5M
+22.94%
-2.0M
+23.58%
-1.6M
-190.39%
Total Shares Outstanding
554.0M
+1,680.58%
31.1M
+37.59%
22.6M
+1,697.51%
1.3M
-99.15%
Cash Flow
Cash from Operating Activities
-171,305
-29.87%
-244,269
+117.09%
-112,521
-93.30%
-1.7M
-32.64%
Capital Expenditures
0
-100.00%
1,196
N/A
0
-100.00%
1,656
+75.61%
Cash from Investing Activities
0
-100.00%
113,477
+359.38%
24,702
-2.09%
25,229
-96.09%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
160,000
+481.56%
27,512
-72.49%
100,000
-74.35%
389,858
-84.13%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
-448.31%
+97.43%
-227.07%
N/A
N/A
N/A
Return on Assets
-1,260.44%
+380.85%
-262.13%
-53.72%
-566.36%
+195.87%
-191.42%
+58.74%
Return on Equity
12.62%
-59.18%
30.92%
-84.79%
203.32%
+104.74%
-4,289.36%
+2,297.11%
Revenue Growth
-100.00%
+46.44%
-68.29%
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.007
-41.60%
0.01
-85.97%
0.09
+9.86%
0.08
-93.51%
Cash Ratio
0.006
-42.86%
0.01
-79.61%
0.05
+7.07%
0.05
-95.58%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow